Figure 2 | Scientific Reports

Figure 2

From: Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development

Figure 2

MSC treatment affects CD4+ T cell responses in vivo.

Male LDLr KO mice received three i.v. injections of either PBS (control) or 0.5 × 106 MSCs (MSC) and were then fed a Western-type diet (WTD) for eight weeks. (a) CD4+ T cells, as well as the percentage of FoxP3+ regulatory T cells (Treg) within CD4+ T cells, were measured in the circulation throughout the entire experiment by flow cytometry. (b) After eight weeks, effector CD4+ T cells, determined as CD62L− within CD4+ T cells, as well as T cell subsets of CD4+ T cells in the circulation and spleen were determined by flow cytometry. All values are expressed as mean ± SEM and representative of six mice per group. *P < 0.05, **P < 0.01, ***P < 0.001.

Back to article page